Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
71,531,081
Total 13F shares
24,050,108
Share change
+20,633,033
Total reported value
$357,352,000
Price per share
$14.86
Number of holders
40
Value change
+$306,574,000
Number of buys
39

Quarterly Holders Quick Answers

What is CUSIP 00509G209?
CUSIP 00509G209 identifies ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) as of Q3 2021

As of 30 Sep 2021, Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,050,108 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Sands Capital Ventures, LLC, BlackRock Inc., Rock Springs Capital Management LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, Laurion Capital Management LP, GUARDIAN POINT CAPITAL, LP, and Woodline Partners LP. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.